FDA seeks Public Comments on Homoeopathic Product Regulation

by

Reproduced from Web: http://www.regulations.gov/#!documentDetail;D=FDA-2015-N-0540-0001
The Food and Drug Administration (FDA) is has announced a public hearing to obtain information and comments from stakeholders about the current use of human drug and biological products labeled as homeopathic, as well as the Agency’s regulatory framework for such products.
The products under consideration include prescription drugs and biological products labeled as homeopathic and over-the-counter (OTC) drugs labeled as homeopathic.
FDA is seeking participants for the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, and industry. FDA is seeking input on a number of specific questions, but is interested in any other pertinent information participants would like to share.”
Written or electronic comments are invited until June 22, 2015.
You may submit your comments at http://www.regulations.gov/#!submitComment;D=FDA-2015-N-0540-0001